Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 16, Number 9—September 2010
Research

Trends in Hospitalizations for Peptic Ulcer Disease, United States, 1998–20051

Lydia B. Feinstein2, Robert C. Holman, Krista L. Yorita Christensen, Claudia A. Steiner, and David L. SwerdlowComments to Author 
Author affiliations: Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (L.B. Feinstein, R.C. Holman, K.L. Yorita Christensen, D.L. Swerdlow); Agency for Healthcare Research and Quality, Rockville, Maryland, USA (C.A. Steiner)

Main Article

Table 3

Number of hospitalizations and the age-adjusted and age-specific hospitalization rates for any-listed discharge diagnoses that included Helicobacter pylori infection, United States, 1998–2005*

Characteristic 1998
 2005
 % Rate change β-coefficient‡
No. (SE) Rate† (95% CI) No. (SE) Rate† (95% CI)
Age, y
<20 1,320 (151) 1.7 (1.3–2.0) 1,718 (276) 2.1 (1.4–2.8) +24 0.040§
20–44 14,617 (648) 14.1 (12.9–15.3) 10,391 (457) 9.9 (9.0–10.7) −30 −0.436¶
45–64 25,287 (955) 43.4 (40.2–46.6) 17,923 (724) 24.6 (22.7–26.6) −43 −2.265¶
>65
 56,593 (1,866)
 163.5 (152.9–174.0)
27,733 (1,009)
 75.4 (70.0–80.8)
 −54
 −10.647¶
Sex
M 47,162 (1,450) 38.9 (37.2–40.6) 28,535 (946) 20.6 (19.6–21.6) −47 −1.854¶
F
 50,656 (1,830)
 33.4 (31.7–35.0)
29,220 (1,078)
 18.0 (17.0–18.9)
 −46
 −1.909¶
Race/ethnicity#
White 51,235 (2,353) 23.2 (21.7–24.7) 23,735 (1,117) 10.3 (9.6–11.0) −56 −1.649¶
Black 11,724 (887) 44.1 (39.7–48.6) 7,480 (561) 23.6 (21.1–26.1) −47 −1.926¶
Hispanic 7,305 (839) 41.8 (34.0–49.6) 7,075 (720) 24.5 (21.1–27.9) −41 0.131§
Asian/Pacific Islander
 2,563 (361)
 34.0 (26.2–41.9)
1,771 (252)
 15.8 (12.0–19.6)
 −54
 −1.471¶
Region
Northeast 17,551 (1,588) 31.4 (27.8–35.1) 11,285 (681) 19.3 (17.6–21.0) −39 −1.392¶
Midwest 23,644 (1,430) 36.9 (33.6–40.2) 12,116 (722) 17.9 (16.3–19.5) −52 −2.229¶
South 37,929 (2,100) 39.3 (36.4–42.1) 23,603 (1,476) 21.6 (19.8–23.4) −45 −2.193¶
West
 18,699 (1,038)
 33.6 (30.8–36.3)
10,766 (738)
 16.5 (14.8–18.1)
 −51
 −1.493¶
Total 97,823 (3,156) 35.9 (34.3–37.5) 57,770 (1,925) 19.2 (18.3–20.1) −47 −1.884¶

*Diagnosis codes 41.86 from the International Classification of Diseases, 9th Revision, Clinical Modification. National estimates were determined by using the Nationwide Inpatient Sample (21). All H. pylori diagnoses are 1 of as many as 15 diagnoses.
†Per 100,000 population.
‡β-coefficient from linear regression analysis, using a weighted least-squares technique, of the annual rate over the years of the study period. The p value corresponds to the test of the null hypothesis that the coefficient for year is zero.
§p≥0.05.
¶p<0.001.
#Race/ethnicity was missing for 26.0% of the patients hospitalized. Data were insufficient for the race/ethnicity category American Indian/Alaska Native.

Main Article

References
  1. Sandler  RS, Everhart  JE, Donowitz  M, Adams  E, Cronin  K, Goodman  C, The burden of selected digestive diseases in the United States. Gastroenterology. 2002;122:1500–11. DOIPubMedGoogle Scholar
  2. Papatheodoridis  GV, Sougioultzis  S, Archimandritis  AJ. Effects of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on peptic ulcer disease: a systematic review. Clin Gastroenterol Hepatol. 2006;4:130–42. DOIPubMedGoogle Scholar
  3. Marshall  BJ, Warren  JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1:1311–5. DOIPubMedGoogle Scholar
  4. Behrman  SW. Management of complicated peptic ulcer disease. Arch Surg. 2005;140:201–8. DOIPubMedGoogle Scholar
  5. Labenz  J, Borsch  G. Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion. 1994;55:19–23. DOIPubMedGoogle Scholar
  6. Ng  EK, Lam  YH, Sung  JJ, Yung  MY, To  KF, Chan  AC, Eradication of Helicobacter pylori prevents recurrence of ulcer after simple closure of duodenal ulcer perforation: randomized controlled trial. Ann Surg. 2000;231:153–8. DOIPubMedGoogle Scholar
  7. el-Serag  HB, Sonnenberg  A. Opposing time trends of peptic ulcer and reflux disease. Gut. 1998;43:327–33. DOIPubMedGoogle Scholar
  8. Lewis  JD, Bilker  WB, Brensinger  C, Farrar  JT, Strom  BL. Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications. Am J Gastroenterol. 2002;97:2540–9. DOIPubMedGoogle Scholar
  9. Centers for Disease Control and Prevention. Knowledge about causes of peptic ulcer disease—United States, March–April 1997. MMWR Morb Mortal Wkly Rep. 1997;46:985–7. PubMedGoogle Scholar
  10. Munnangi  S, Sonnenberg  A. Time trends of physician visits and treatment patterns of peptic ulcer disease in the United States. Arch Intern Med. 1997;157:1489–94. DOIPubMedGoogle Scholar
  11. Tytgat  GN. Treatment of Helicobacter pylori infection: management of patients with ulcer disease by general practitioners and gastroenterologists. Gut. 1998;43(Suppl 1):S24–6. DOIPubMedGoogle Scholar
  12. US Department of Health and Human Services. Healthy People 2010, vol. 1, November 2000 [cited 2010 Jul 12]. http://www.healthypeople.gov/Document/tableofcontents.htm#volume1
  13. Everhart  JE, Kruszon-Moran  D, Perez-Perez  GI, Tralka  TS, McQuillan  G. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis. 2000;181:1359–63. DOIPubMedGoogle Scholar
  14. de Martel  C, Parsonnet  J. Helicobacter pylori infection and gender: a meta-analysis of population-based prevalence surveys. Dig Dis Sci. 2006;51:2292–301. DOIPubMedGoogle Scholar
  15. Higham  J, Kang  JY, Majeed  A. Recent trends in admissions and mortality due to peptic ulcer in England: increasing frequency of haemorrhage among older subjects. Gut. 2002;50:460–4. DOIPubMedGoogle Scholar
  16. Kang  JY, Elders  A, Majeed  A, Maxwell  JD, Bardhan  KD. Recent trends in hospital admissions and mortality rates for peptic ulcer in Scotland 1982–2002. Aliment Pharmacol Ther. 2006;24:65–79. DOIPubMedGoogle Scholar
  17. Sonnenberg  A. Peptic ulcer. In: JE Everhart, editor. Digestive diseases in the United States: epidemiology and impact. Washington: US Government Printing Office; 1994. p. 357–408.
  18. Sonnenberg  A. Time trends of ulcer mortality in Europe. Gastroenterology. 2007;132:2320–7. DOIPubMedGoogle Scholar
  19. Sonnenberg  A. Time trends of ulcer mortality in non-European countries. Am J Gastroenterol. 2007;102:1101–7. DOIPubMedGoogle Scholar
  20. Post  PN, Kuipers  EJ, Meijer  GA. Declining incidence of peptic ulcer but not of its complications: a nation-wide study in the Netherlands. Aliment Pharmacol Ther. 2006;23:1587–93. DOIPubMedGoogle Scholar
  21. Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project. Nationwide Inpatient Sample (NIS), 1998–2005 data; 2007 [cited 2010 Jul 12]. http://www.hcup-us.ahrq.gov/nisoverview.jsp
  22. Steiner  C, Elixhauser  A, Schnaier  J. The healthcare cost and utilization project: an overview. Eff Clin Pract. 2002;5:143–51. PubMedGoogle Scholar
  23. US Public Health Service and Health Care Financing Administration. International classification of diseases, 9th rev., clinical modification, 6th ed. (CD-ROM). Washington: US Department of Health and Human Services; 2006.
  24. US Bureau of the Census. Intercensal estimates of the population by age, sex, and race: 1998–2005. Washington: The Bureau; 2006.
  25. Research Triangle Institute. SUDAAN users manual, release 8.0. Research Triangle Park (NC): The Institute; 2001.
  26. Agency for Healthcare Research and Quality. Healthcare Cost and Utilization project, Introduction to the HCUP Nationwide Inpatient Sample (NIS), 2005; 2007 [cited 2010 Jul 12]. http://www.hcup-us.ahrq.gov/nisoverview.jsp
  27. Gillum  BS, Graves  EJ, Jean  L. Trends in hospital utilization: United States, 1988–92. Vital Health Stat 13. 1996;124:1–71. PubMedGoogle Scholar
  28. Klein  RJ, Schoenborn  CA. Age adjustment using the 2000 projected U.S. population. Healthy People 2010 Stat Notes 2001 [cited 2010 Jul 12]. http://www.cdc.gov/nchs/products/hp_pubs.htm
  29. Elashoff  JD, Grossman  MI. Trends in hospital admissions and death rates for peptic ulcer in the United States from 1970 to 1978. Gastroenterology. 1980;78:280–5.PubMedGoogle Scholar
  30. Manual  D, Cutler  A, Goldstein  J, Fennerty  MB, Brown  K. Decreasing prevalence combined with increasing eradication of Helicobacter pylori infection in the United States has not resulted in fewer hospital admissions for peptic ulcer disease–related complications. Aliment Pharmacol Ther. 2007;25:1423–7. DOIPubMedGoogle Scholar
  31. Kurata  JH, Elashoff  JD, Haile  BM, Honda  GD. A reappraisal of time trends in ulcer disease: factors related to changes in ulcer hospitalization and mortality rates. Am J Public Health. 1983;73:1066–72. DOIPubMedGoogle Scholar
  32. Sonnenberg  A. Temporal trends and geographical variations of peptic ulcer disease. Aliment Pharmacol Ther. 1995;9(Suppl 2):3–12. PubMedGoogle Scholar
  33. Sonnenberg  A. Causes underlying the birth-cohort phenomenon of peptic ulcer: analysis of mortality data 1911–2000, England and Wales. Int J Epidemiol. 2006;35:1090–7. DOIPubMedGoogle Scholar
  34. Kurata  JH, Haile  BM, Elashoff  JD. Sex differences in peptic ulcer disease. Gastroenterology. 1985;88:96–100. PubMedGoogle Scholar
  35. Kozak  LJ. Underreporting of race in the National Hospital Discharge Survey. Adv Data. 1995;:1–12. PubMedGoogle Scholar
  36. Demma  LJ, Holman  RC, Sobel  J, Yorita  KL, Hennessy  TW, Paisano  EL, Epidemiology of hospitalizations associated with ulcers, gastric cancers, and Helicobacter pylori infection among American Indian and Alaska Native persons. Am J Trop Med Hyg. 2008;78:811–8. PubMedGoogle Scholar

Main Article

1Presented in part at the Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and Infectious Diseases Society of America; 2008 Oct 28; Washington, DC (abstract number L-4129).

2Current affiliation: University of North Carolina, Chapel Hill, North Carolina, USA.

Page created: August 28, 2011
Page updated: August 28, 2011
Page reviewed: August 28, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external